Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)
- Conditions
- Opioid Cessation
- Interventions
- Behavioral: Motivational Interviewing and Physician Guided Opioid Weaning
- Registration Number
- NCT02070003
- Lead Sponsor
- Stanford University
- Brief Summary
The investigators aim to characterize the relationship between changes in emotional distress, opioid use, and pain throughout surgery and recovery. Additionally, the investigators aim to compare the effectiveness of post-surgical motivational interviewing and physician-guided opioid weaning vs. usual care on reducing persistent opioid use. Overall, the proposed research will advance knowledge regarding the role of psychological factors contributing to persistent opioid use after surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 104
- Age 18+
- Undergoing a scheduled surgery
- English speaking
- Ability and willingness to complete questionnaires and assessments.
- Any conditions causing inability to complete baseline, telephone and internet assessments (e.g. education, cognitive ability, mental status, medical status)at the discretion of the investigator.
- Known Pregnancy
- Elevated Suicidality as assessed by an answer of 2 or greater on question 9 of the Beck Depression Inventory assessing suicidal thoughts.
- Coexisting Chronic Pain Disorder of moderate severity in area other than surgical target
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Motivational Interviewing and Physician Guided Opioid Weaning Motivational Interviewing and Physician Guided Opioid Weaning Patients will go through motivational interviewing with the study physician via phone once a week for 7 weeks, and once a month up to a year as applicable, until patient completes the protocol.
- Primary Outcome Measures
Name Time Method Trial Feasibility - The proportion of people consented who complete the study in the group to which they were randomized Duration of the study - up to 2 years per participant Factors that contribute to non-completion of the study, measured at baseline for each patient, will be analyzed.
- Secondary Outcome Measures
Name Time Method Efficacy - time to opioid cessation Duration of the trial - Up to 2 years per participant Time to opioid cessation between the two groups will be analyzed using survival analysis
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Palo Alto, California, United States